STOCKWATCH
·
Medical Electronics
Quarterly ResultApr 30, 2026, 07:07 AM

BFLY Q1 Revenue $26.5M, +25% YoY; Adj EBITDA ($6.1M); Reaffirms FY26 Guidance

AI Summary

Butterfly Network, Inc. reported strong first-quarter 2026 financial results, with revenue reaching $26.5 million, a 25% increase year-over-year, and gross margin improving to 68.9%. The company also significantly reduced its Adjusted EBITDA loss to ($6.1 million), a 32% improvement from the prior year. Butterfly reaffirmed its full-year 2026 revenue and Adjusted EBITDA guidance, while also highlighting operational advancements including FDA clearance for its Gestational Age AI Tool and expansion of its Butterfly Garden Ecosystem and Compass AI™ solutions.

Key Highlights

  • Q1 Revenue: $26.5 million, up 25% year-over-year.
  • Q1 Gross Margin: 68.9%, an increase of 600 basis points year-over-year.
  • Q1 Adjusted EBITDA loss: ($6.1 million), an improvement of 32% year-over-year.
  • Q1 Net Loss: ($12.7 million), compared to ($14.0 million) in prior year.
  • Q1 EPS: $(0.05), compared to $(0.06) in the prior year period.
  • Reaffirmed FY26 Revenue guidance: $117 million to $121 million (20%-24% growth).
  • Reaffirmed FY26 Adjusted EBITDA loss guidance: ($21 million) to ($25 million).
BFLY
Medical Electronics
Butterfly Network, Inc.

Price Impact